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Abstract
Aims: Our aim was to validate patient-specific software integrating baseline anatomy and biomechanical 
properties of both the aortic root and valve for the prediction of valve morphology and aortic leaflet cal-
cium displacement after TAVI.
Methods and results: Finite element computer modelling was performed in 39 patients treated with 
a Medtronic CoreValve System (MCS; n=33) or an Edwards SAPIEN XT (ESV; n=6). Quantitative axial 
frame morphology at inflow (MCS, ESV) and nadir, coaptation and commissures (MCS) was compared 
between multislice computed tomography (MSCT) post TAVI and a computer model as well as displace-
ment of the aortic leaflet calcifications, quantified by the distance between the coronary ostium and the 
closest calcium nodule. Bland-Altman analysis revealed a strong correlation between the observed (MSCT) 
and predicted frame dimensions, although small differences were detected for, e.g., Dmin at the inflow 
(mean±SD MSCT vs. model: 21.6±2.4 mm vs. 22.0±2.4 mm; difference±SD: –0.4±1.3 mm, p<0.05) and 
Dmax (25.6±2.7 mm vs. 26.2±2.7 mm; difference±SD: –0.6±1.0 mm, p<0.01). The observed and predicted 
calcium displacements were highly correlated for the left and right coronary ostia (R2=0.67 and R2=0.71, 
respectively p<0.001).
Conclusions: Dedicated software allows accurate prediction of frame morphology and calcium displace-
ment after valve implantation, which may help to improve outcome.
KEYWORDS
• aortic stenosis
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modelling
• transcatheter aortic 
valve implantation 
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Computer-simulated TAVI device-host interaction
Introduction
Transcatheter aortic valve implantation (TAVI) is increasingly 
used to treat selected patients with aortic stenosis and has been 
shown to improve survival and quality of life1-5. However, TAVI 
is associated with a number of complications that remain to be 
solved in order to improve safety and efficacy6.
Although some of the complications may stem from patient-, 
procedure- and/or operator-related factors, some arise from spe-
cific device-host interactions. With respect to the latter, one might 
cite as examples incomplete and/or non-circular frame expansion 
due to the presence of aortic root calcifications leading to paraval-
vular regurgitation, unexpected mobilisation of calcified leaflets 
leading to coronary obstruction, and dissection or rupture of the 
aortic root even in the presence of appropriate valve size selec-
tion7-13. Device-host interactions are clinically difficult to predict 
because of the large variations in the geometry and dimensions of 
the aortic root in addition to the variations in the amount and dis-
tribution of calcium between patients. The increasing number and 
spectrum of patients referred for TAVI as well as the increasing 
valve types available necessitate patient-specific tools predicting 
device-host interaction for both patient selection and procedure 
planning (i.e., selection of the valve that best fits the individual 
patient). Finite element computer simulation of a TAVI procedure 
based upon the integration of the patient-specific anatomy, the 
physical and mechanical properties of the valve and the biome-
chanical properties of the aortic root, may help to define in vivo 
device-host interactions, thereby enhancing the safety of TAVI14-22.
In this paper, such a patient-specific cardiovascular computer 
model for the prediction of the in vivo morphology of the Medtronic 
CoreValve® Revalving System (MCS) (Medtronic, Minneapolis, 
MN, USA) and the Edwards SAPIEN XT Transcatheter Heart Valve 
(ESV) (Edwards Lifesciences, Irvine, CA, USA) and the displace-
ment of the calcified aortic leaflets immediately after implantation 
is reported and validated by comparing the findings derived from 
the model (predicted) with those from multislice computed tomog-
raphy (MSCT) performed shortly after TAVI (observed).
Methods
STUDY POPULATION AND MSCT
Thirty-nine patients who received a 26/29 mm MCS or a 23/26 mm 
ESV and who underwent MSCT pre and post TAVI were studied. 
Sizing of the valves was guided by the manufacturer’s recommen-
dations. All patients underwent MSCT pre TAVI and post TAVI. 
Details of the MSCT have been described previously7. Briefly, 
end-systolic data sets were reconstructed using a single-segmen-
tal reconstruction algorithm: slice thickness 1.5 mm; increment 
0.4 mm; medium-to-smooth convolution kernel (B26f) resulting 
in a spatial resolution of 0.6-0.7 mm in-plane and 0.4-0.5 mm 
through-plane and a temporal resolution of 72 ms.
COMPUTER MODELLING
First, finite element computer models of the 26/29 mm MCS and 
23/26 ESV frame were developed based on a detailed evaluation 
of: a) the frame morphology using microscopic measurements and 
micro-computed tomography (resolution 30 microns), and b) the 
mechanical characteristics of the nitinol and cobalt-chromium 
frame of both valves by performing in vitro radial compression 
tests at body temperature. During these tests, the frame diameter 
was reduced over the full frame length using a segmental com-
pression mechanism, while the radial force was recorded (RX650; 
Machine Solutions, Flagstaff, AZ, USA).
Next, patient-specific three-dimensional (3D) computer mod-
els of the native aortic root, including the (calcified) native leaf-
lets were constructed from clinical pre-TAVI MSCT images 
using image segmentation techniques (Mimics software v16.0; 
Materialise, Leuven, Belgium). A fixed leaflet thickness of 
1.5 mm was used for the non-calcified portion of the native 
leaflets. Varying mechanical properties were then automati-
cally assigned to different tissue regions. The model parameters 
related to the tissue behaviour were calibrated using the MSCT 
data sets of the first 14 patients and validated in 39 patients. 
The calibration started by performing valve implantation simula-
tions in the first 14 patients using an initial set of biomechanical 
properties of the left ventricular outflow tract (LVOT)-aortic root 
complex. These properties were iteratively adjusted after analy-
sis of the clinical MSCT post TAVI (back calculation), and the 
final resulting tissue properties were subsequently used in the 
validation analysis.
The computer-generated valve frames were then implanted 
virtually into the patient’s specific anatomy using finite element 
computer simulations. All simulations were performed using the 
Abaqus/Explicit v6.12 finite element solver (Dassault Systèmes, 
Paris, France). In each computer-simulated implantation, all steps 
of the clinical or in vivo implantation were respected and consisted 
of predilatation, valve size selection, depth of implantation and 
post-dilatation if applied. The depth of implantation was matched 
with the actual depth of implantation (i.e., depth of implantation 
during actual valve implantation) by overlaying the 3D aortic root 
model derived from the software after simulation of valve implan-
tation with the one derived from MSCT post TAVI followed by 
evaluating the resulting alignment of the inflow of the valve frame 
of the 3D model with the one of the MSCT post TAVI that was 
used as reference. Simulations were repeated until correct align-
ment was obtained which was used for the validation analysis. For 
the pre- and (if applicable) post-dilatation, the same size of bal-
loon that was used during the in vivo implantation was used during 
the computer simulation.
MEASUREMENTS OF THE MCS AND ESV FRAME 
DIMENSIONS
The observed (MSCT post) and predicted (computer model) axial 
frame morphology was quantified at four predefined levels of the 
MCS frame as described previously7: 1) ventricular end, 2) nadir, 
and 3) central coaptation of the MCS leaflets, and 4) commissures. 
Given the tubular shape of the ESV, only the inflow was investi-
gated for this valve (Figure 1).
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Measurements were performed on axial slices so that the con-
nection points of a particular level appeared simultaneously. 
A curve through the centre of all struts was used to calculate the 
perimeter and cross-sectional area. The smallest and largest per-
pendicular frame diameters were automatically derived from this 
curve. These basic measures describing frame geometry (i.e., 
Dmin, Dmax, perimeter and cross-sectional area) were chosen to 
compare predicted and observed frame deformation. These are 
variables that are directly measured and, thus, not derived from 
other measures. At variance with derived measures such as ellip-
ticity and underexpansion, the direct measures provide a better 
understanding of the modelling accuracy/errors.
For each level of the observed MCS and ESV (MSCT post TAVI), 
the centre of the struts was manually identified. Two blinded oper-
ators (R. Rodriguez-Olivares, P. Mortier) performed all measure-
ments in order to quantify the operator variability of this manual 
Figure 1. Levels of measurement on the MCS and ESV. The geometry 
of predicted (model - left) and observed (MSCT - right) MCS (top) 
frame was quantified at the ventricular end (A and A’), nadir (B and 
B’), central coaptation (C and C’) and commissures (D and D’). For 
the ESV (bottom), only the ventricular end (E and E’) was evaluated.
process. The correlation coefficient varied between 0.92 and 1.00 
without any statistical difference between the two operators for all 
measurements at all levels. For the predicted frames (computer 
model), the curves at the different levels were automatically gen-
erated, making the complete measurement process on the simula-
tion results fully automated (no operator variability).
QUANTIFICATION OF LEAFLET CALCIUM DISPLACEMENT
Postoperative MSCT was also used to evaluate the accuracy of 
the predicted displacement of the native leaflet calcifications after 
MCS implantation. The position of the displaced calcium was 
quantified by measuring the smallest distance between a calcifica-
tion nodule and the coronary ostium for both the MSCT post TAVI 
and the computer model. This measure was chosen as it may pro-
vide relevant insights regarding the risk of coronary occlusion. For 
this purpose, a 3D reconstruction of the MSCT post TAVI was gen-
erated and the calcifications were separated from the MCS frame. 
Such separation was not required for the 3D simulation where the 
calcifications were identified as separate regions prior to MCS 
deployment. The coronary ostium was identified by defining three 
points around the circumference of the ostium on the 3D model of 
the aortic root. The centre of the circle determined by these three 
points was used to define the coronary ostium. The distance from 
the coronary ostium to each point of the mesh representing the 
leaflet calcification was then calculated, and the minimal value 
was detected (Figure 2). A distance measurement was not done if 
the amount of calcium on the aortic leaflet corresponding to the 
coronary artery was too small to be reliably distinguished from the 
prosthesis frame after deployment.
Figure 2. Quantification of leaflet calcium displacement. The 
displacement of leaflet calcifications was quantified by measuring 
the smallest distance between the coronary ostium and the closest 
calcium nodule (green line). Coronary ostium was identified by 
picking three points (blue) on the 3D surface representing the aortic 
root (not shown) around the circumference of the ostium. The centre 
of the circle going through these three points was used for the 
distance calculation (shown in red).
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STATISTICAL METHODS
Data are presented as a median (25th to 75th quartile) or 
mean±standard deviation (SD) as appropriate. The coefficient 
of determination (R-squared) was determined. Paired compari-
sons between the measurements on the clinical MSCT post TAVI 
and those derived from the computer simulation were carried out 
using the paired Student’s t-test or the Wilcoxon signed-rank test 
as appropriate. Difference plots were constructed according to the 
Bland-Altman method. SPSS Version 21.0 (IBM Corp., Armonk, 
NY, USA) was used. Statistical significance was defined as a two-
tailed p<0.05.
Results
The clinical characteristics of the patients are shown in Table 1. All 
patients underwent transfemoral TAVI following balloon valvulo-
plasty of the aortic valve just before valve implantation (20 mm 
balloon in nine patients, 22 mm balloon in 12 patients, 23 mm bal-
loon in 11 patients, and 25 mm balloon in one patient). A 26 mm 
MCS was implanted in 11 patients and a 29 mm in 22 patients, 
a 23 and 26 mm ESV was implanted in one and five patients, 
respectively. Four out of the 39 patients underwent balloon dilata-
tion after TAVI: 23 mm balloon after 26 mm MCS in one patient, 
25 mm balloon after 26 and 29 mm MCS in two patients, 26 mm 
balloon after 29 mm MCS in one patient.
COMPARISON OF PREDICTED AND OBSERVED FRAME 
DIMENSIONS
The mean (±SD) of the observed (MSCT) and predicted 
(model) dimensions at the various levels of the frame and 
Table 1. Clinical characteristics.
mean±SD median [25th - 75th percentile] n (%) n=39
Age (yrs) 81±6
Male 18 (46%)
Height (cm) 166±9
Weight (kg) 70 [64-77]
Body mass index (kg/m2) 25.6 [24.5-27.1]
Logistic EuroSCORE 14.0 [9.0-18.0]
Echocardio-
graphy
Left ventricular ejection fraction (%) 56±12
Aortic valve area (cm2) 0.65±0.19
Peak gradient (mmHg) 75±23
Multislice 
computed 
tomography
Minimal annulus diameter (Dmin), (mm) 21.3±2.0
Maximal annulus diameter (Dmax), (mm) 26.6±2.4
Mean annulus diameter (mm) 23.9±1.9
Circumference (mm) 77.5±6.4
Area (cm2) 4.4±0.7
Aortic valve Agatston score 2,958 [2,003-3,617]
Total volume 1,673 [921-2,595]
Equivalent mass 651 [375-815]
Ratio nominal valve size/Dmin annulus 1.3±0.1
Ratio nominal valve size/Dmax annulus 1.0±0.1
their differences are shown in Table 2. There was a small 
degree of overestimation of the dimensions of the frame by the 
model at the inflow, nadirs and coaptation but not at the level 
of the commissures. Overall, there was a strong correlation 
(R-squared) between the observed and predicted measurements 
for all dimensions, except for the Dmin and Dmax at the nadirs 
and the coaptation levels of the MCS valve where the correla-
tion was moderate.
The correlation between MSCT and model is illustrated by the 
scatter and difference plots with limits of agreement for all dimen-
sions at the level of the inflow in Figure 3 and Figure 4, showing 
the small but insignificant overestimation of the frame dimensions 
by the model.
COMPARISON OF PREDICTED AND OBSERVED LEAFLET 
CALCIUM DISPLACEMENT
The distance between the coronary ostium and calcification on 
the nearest leaflet could be measured for 27 left coronaries and 24 
right coronaries. The measurements were not possible on MSCT 
if there was no calcium on the corresponding native valve leaflet 
prior to TAVI or if the calcium spot was too small to differentiate 
it from the prosthesis frame post TAVI. The measured (MSCT) 
and predicted (model) distances from coronary ostium to cal-
cium nodule were highly correlated for the left and right coro-
nary ostia (respectively, R2=0.67 and R2=0.71, p<0.001 for both). 
There was a small overestimation by the model for the left coro-
nary artery (MSCT vs. model respectively: mean distance±SD: 
8.3±3.8 mm vs. 9.5±4.0 mm; difference±SD: –1.1±2.4 mm, 
p=0.02) and also for the right coronary artery (MSCT vs. model 
respectively: mean distance±SD: 8.1±2.5 mm vs. 9.0±2.7 mm; 
difference±SD: –0.9±1.5 mm, p=0.006).
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Figure 3. Scatter and difference plots of the minimum (Dmin, upper 
panels) and maximal diameters (Dmax, lower panels) measured at 
the inflow by MSCT and model. On the scatter plots (left) the linear 
line of best fit and 95% confidence intervals are shown. On the 
difference plots (right) the mean and 95% confidence intervals of the 
difference are shown.
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A qualitative comparison of the predicted and observed posi-
tions of the calcified native leaflets after TAVI is shown for 
four representative cases in Figure 5. Scatter and difference 
plots with limits of agreement are shown for both the left and 
right coronary arteries (Figure 6), showing the small but insig-
nificant overestimation of the predicted distance from coronary 
ostium to calcium nodule.
Table 2. Comparison of frame dimensions obtained from the model with those measured on MSCT post implantation.
Level of 
measurement
Dimension
Coefficient of 
determination (R2)
MSCT Observer 1 Model
Difference  
(MSCT - Model)
Inflow Dmin (mm) 0.72*** 21.6±2.4 22.0±2.4 –0.4±1.3*
Dmax (mm) 0.86*** 25.6±2.7 26.2±2.7 –0.6±1.0**
Circumference (mm) 0.84*** 74.5±7.1 76.6±6.5 –2.1±2.9***
Area (mm2) 0.84*** 435.8±85.5 456.2±83.4 –20.4±34.6**
Nadir Dmin (mm) 0.44*** 21.1±1.3 21.4±1.0 –0.3±1.0
Dmax (mm) 0.48*** 24.4±1.0 24.5±1.2 –0.1±0.9
Circumference (mm) 0.67*** 71.6±2.9 72.2±2.4 –0.6±1.7*
Area (mm2) 0.71*** 403.1±34.5 409.9±27.3 –6.8±18.6*
Coaptation Dmin (mm) 0.46*** 21.3±1.0 22.4±1.0 –1.1±0.8***
Dmax (mm) 0.48*** 22.9±0.8 24.0±0.9 –1.1±0.7***
Circumference (mm) 0.64*** 69.3±2.2 73.0±2.6 –3.8±1.5***
Area (mm2) 0.64*** 379.7±24.7 422.9±29.8 –43.2±17.8***
Commissures Dmin (mm) 0.81*** 28.5±2.1 28.1±2.1 0.4±1.0**
Dmax (mm) 0.79*** 29.9±1.9 29.8±1.8 0.1±0.9
Circumference (mm) 0.83*** 91.5±6.2 91.0±5.7 0.5±2.6
Area (mm2) 0.83*** 666.2±91.1 657.9±83.4 8.4±38.1
*p<0.05, **p<0.01, ***p<0.001. For inflow: n=39 patients (MCS 33, ESV 6). For other levels n=33 (MCS). For more details, see text.
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Figure 4. Scatter and difference plots of the cross-sectional area 
(upper panels) and perimeter (lower panels) measured at the inflow 
of the MCS and ESV by MSCT and model. On the scatter plots (left) 
the linear line of best fit and 95% confidence intervals are shown. On 
the difference plots (right) the mean and 95% confidence intervals of 
the difference are shown.
Discussion
The present study concerns the description and technical evalua-
tion of a computer model that allows in vivo prediction of frame 
geometry and calcium displacement before actual valve implanta-
tion by integrating the pre-TAVI MSCT-derived anatomy and the 
physical characteristics of the valve chosen to be implanted.
Overall, there was a high agreement between the predicted and 
observed dimensions of the valve frame. The model, however, 
overestimated the dimensions at all levels except for the com-
missures (MCS frame). Despite the statistically significant differ-
ences, the absolute value of these differences is small. This also 
holds true for the predicted and observed displacement of the cal-
cified aortic leaflets. The distance from the coronary ostium to the 
calcification on the nearest leaflet was slightly overestimated by 
the model.
The obvious question is what causes the overestimation and 
whether it has any eventual clinical consequences if the model 
were to be used in clinical practice for patient selection and TAVI 
planning (i.e., valve type and size). This is particularly the case for 
the inflow portion of the valve as this is the site where most of the 
complications occur, for example paravalvular regurgitation and 
bundle branch block and also the rare but dramatic event of coro-
nary obstruction7-13. Most likely, the overestimation unveils limi-
tations of the software. For example, the 3D aortic root models 
contain simplifications with respect to the real anatomy, and the 
assigned mechanical tissue properties may not fully reflect real 
tissue behaviour. Another source of error may have been unde-
tected differences in the depth of implantation between the real 
and virtual valve implantation. The depth of implantation assessed 
by MSCT post TAVI was used during computer simulation. 
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However, despite care in correctly aligning the depth of implan-
tation, it is conceivable that subtle differences in the depth of 
implantation between the actual valve implantation and simulation 
have occurred, thereby introducing differences in frame geometry 
between MSCT post TAVI and the model. As mentioned above, 
Figure 5. Displacement of leaflet calcifications after valve implantation. Qualitative comparison of the observed (MSCT post TAVI – B) and 
predicted (model – C) position of the calcified native leaflets after TAVI for four representative cases. The positions of the aortic leaflet 
calcifications before TAVI are shown in A.
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Figure 6. Scatter and difference plots of the measured distance from 
the left (upper panels) and right coronary ostium (lower panels) to 
the nearest calcium nodule by MSCT and model. On the scatter plots 
(left) the linear line of best fit and 95% confidence intervals are 
shown. On the difference plots (right) the mean and 95% confidence 
intervals of the difference are shown.
the model slightly overestimated the dimensions of the frame. 
The potential clinical impact of the modelling errors is currently 
unknown and can only be evaluated by future studies assessing 
the predictive power of the model with respect to complications 
such as paravalvular regurgitation and conduction disturbances.
There is growing interest in the development of software 
which is able to construct detailed geometric anatomic models 
from patient-specific diagnostic images and software that allows 
computer simulation of TAVI in order to predict valve configu-
ration in the patient-specific anatomy, thereby helping the physi-
cian to select the valve (type and size) that best fits the individual 
patient14-22. A number of studies have employed finite element 
computer modelling to deploy a transcatheter aortic valve virtu-
ally into a patient-specific aortic root model14-16,19,21,22. While all 
of these studies have definitely contributed to proving the feasi-
bility of patient-specific TAVI simulations, the validation of the 
modelling results has been limited so far. In the present work, we 
describe for the first time a validation of the predictive power of 
patient-specific TAVI simulations by detailed comparison with 
postoperative imaging.
MSCT has been recommended to improve valve size selec-
tion so as to reduce complications, in particular paravalvular aor-
tic regurgitation23-25. However, the reading and interpretation of 
diagnostic images remain subjective26. As has been shown previ-
ously, selecting a valve in which the nominal dimensions fit with 
the dimension of the aortic annulus is not a guarantee for perfect 
apposition despite optimal positioning7. Similarly, assessing the 
risk of coronary obstruction by using a certain threshold (e.g., 
10 mm) for the distance from the aortic annulus to the coronary 
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ostium is limited by a low sensitivity12. Sixty percent of the cases 
with coronary obstruction reviewed by Ribeiro et al had a coro-
nary ostium height >10 mm, suggesting that other factors might 
be involved, such as the size and location of calcium nodules on 
the leaflets and the size of the sinuses of Valsalva. With respect 
to MSCT-based planning, computer simulation incorporating 
the calcium load of the base of the aortic root including leaf-
lets such as reported in the current study and by Russ et al may 
help to predict coronary obstruction more precisely16. Similarly, 
preoperative assessment of the risk of paravalvular aortic regur-
gitation may be improved by the proposed computer model. The 
case study shown in Figure 7 illustrates the potential of the com-
puter model to provide additional information during preopera-
tive planning, for example to understand the impact of device 
size and position.
The present study is a proof of concept and is indicative of 
the clinical utility of preprocedural computer simulation. Patient-
specific preprocedural planning or personalised medicine is 
requested by many healthcare authorities confronted by increas-
ing healthcare costs as a result of an ageing population and also 
increasing treatment modalities for older patients27,28. The methods 
proposed in this study may serve this goal since and – at variance 
with surgical valve replacement – there is no direct vision of the 
target zone and no excision of calcium that is intrinsically associ-
ated with a higher degree of unpredictability of valve geometry 
and function.
Study limitations
This study is limited by the fact that the validation of the model 
focuses on a limited sample of 26/29 mm MCS and 23/26 mm 
ESV. Therefore, it remains to be elucidated whether the accuracy 
of the model will be similar for all types and sizes of commer-
cially available valves. In addition, the current study focuses on 
the acute frame deformation, and the potential long-term effects of 
device-host interaction (especially in the case of the self-expanda-
ble MCS) are not taken into account.
Conclusions
Dedicated software allows accurate prediction of frame mor-
phology and calcium displacement after TAVI and is a first step 
towards patient-tailored medicine by selecting the type and size 
of valve that best fits the individual patient, thereby improving 
outcome.
Impact on daily practice
A patient-specific computer simulation of a TAVI procedure 
allows the operator to select the valve that best fits the indi-
vidual patient and is projected to improve outcome by reducing 
complications. It is a first step in the development and pro-
motion of personalised medicine as demanded by healthcare 
authorities and society.
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